13F-HR filed by Casdin Capital, LLC
Casdin Capital, LLC filed this 13F-HR for the quarter ended 2020-09-30, filed 2020-11-16, with 45 holding rows worth $2,233,335,000.
- Accession
- 0001534261-20-000014
- Filer
- CIK 1534261
- Filed
- 2020-11-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2020
A holdings report, 45 entries on the cover page, a total value of $2,233,335,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,233,335,000 with VALUE read as thousands by filing date, 13F file number 028-17113. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| INVITAE CORP | 46185L103 | COM | 9,033,943 | $391,621,000 | thousands by filing date | |
| BIOLIFE SOLUTIONS INC COM NEW | 09062W204 | Stock | 5,840,107 | $169,013,000 | thousands by filing date | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 3,808,894 | $162,221,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 1,550,000 | $143,685,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 3,050,000 | $121,909,000 | thousands by filing date | |
| MYOKARDIA INC | 62857M105 | COM | 870,000 | $118,607,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 620,000 | $90,272,000 | thousands by filing date | |
| TWIST BIOSCIENCE CORP | 90184D100 | COM | 1,000,000 | $75,970,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 530,000 | $74,428,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 1,750,000 | $61,250,000 | thousands by filing date | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 1,634,535 | $56,882,000 | thousands by filing date | |
| GENERATION BIO CO | 37148K100 | COM | 1,611,214 | $49,803,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 915,000 | $49,364,000 | thousands by filing date | |
| BURNING ROCK BIOTECH LTD | 12233L107 | SPONSORED ADS | 1,922,150 | $48,208,000 | thousands by filing date | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 1,310,000 | $46,937,000 | thousands by filing date | |
| CODEXIS INC | 192005106 | COM | 3,985,000 | $46,784,000 | thousands by filing date | |
| CAREDX INC | 14167L103 | COM | 1,193,335 | $45,275,000 | thousands by filing date | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 4,500,000 | $44,415,000 | thousands by filing date | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 150,000 | $42,966,000 | thousands by filing date | |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 945,000 | $35,636,000 | thousands by filing date | |
| ADAPTIVE BIOTECHNOLOGIES CORP COM | 00650F109 | Stock | 713,125 | $34,679,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 2,750,000 | $28,325,000 | thousands by filing date | |
| DIANTHUS THERAPEUTICS INC COM | 55910K108 | Stock | 3,346,034 | $22,753,000 | thousands by filing date | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 266,430 | $22,284,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 395,000 | $21,780,000 | thousands by filing date | |
| AMYRIS INC | 03236M200 | COM NEW | 7,390,000 | $21,579,000 | thousands by filing date | |
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 980,000 | $19,855,000 | thousands by filing date | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 820,440 | $18,378,000 | thousands by filing date | |
| ALECTOR INC | 014442107 | COMMON STOCK | 1,650,000 | $17,383,000 | thousands by filing date | |
| DERMTECH INC | 24984K105 | COM | 1,428,572 | $17,071,000 | thousands by filing date | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 190,000 | $15,802,000 | thousands by filing date | |
| BERKELEY LTS INC | 084310101 | COM | 200,000 | $15,272,000 | thousands by filing date | |
| BRISTOL-MYERS SQUIBB CO | 110122157 | RIGHT 99/99/9999 | 6,250,000 | $14,063,000 | thousands by filing date | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 1,441,176 | $11,429,000 | thousands by filing date | |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 1,080,000 | $10,206,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 290,000 | $9,547,000 | thousands by filing date | |
| ILLUMINA INC | 452327109 | COM | 30,000 | $9,272,000 | thousands by filing date | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 289,395 | $8,748,000 | thousands by filing date | |
| ORCHARD THERAPEUTICS PLC | 68570P101 | ADR | 1,870,000 | $7,686,000 | thousands by filing date | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 370,000 | $7,470,000 | thousands by filing date | |
| TURNING PT THERAPEUTICS | 90041T108 | COM | 75,000 | $6,552,000 | thousands by filing date | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 251,515 | $6,290,000 | thousands by filing date | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 139,661 | $4,311,000 | thousands by filing date | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 120,000 | $4,019,000 | thousands by filing date | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 65,000 | $3,335,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001534261-20-000014 | this filing | 2020-11-16 | acceptance time not in the bulk data set |